Skip to product information
1 of 1

Misoprostol Pharmeasy

Mifegest Kit Mifepristone Misoprostol

Mifegest Kit Mifepristone Misoprostol

Regular price $120.00 USD
Regular price Sale price $120.00 USD
Sale Sold out

Trade Name: Mifegest kit

Manufacturer: Misoprostol Pharma

Usage Application: Abortion

Strength: 200 mg mcg

Service Country: Germany, France, USA,

WhatsApp logo Order on WhatsApp

What is Mifegest kit ?

The Mifegest Kit is a pharmaceutical product designed to terminate pregnancies during their early stages. It contains two essential medications: Mifepristone and Misoprostol. These medications are often prescribed together to ensure the most effective results. Let's take a closer look at each component of the kit:


Mifepristone, also known as the "abortion pill" or RU-486, is an anti-progesterone medication. Progesterone is a hormone that plays a crucial role in maintaining pregnancy by supporting the growth of the uterine lining. Mifepristone works by blocking the action of progesterone, causing the uterine lining to break down, and ultimately, ending the pregnancy.


Misoprostol is a prostaglandin analogue that is often used in conjunction with Mifepristone. It helps to induce uterine contractions, which are necessary for the expulsion of the pregnancy tissue. This medication is typically taken 24 to 48 hours after Mifepristone.

How Does the Mifegest Kit Work?

The Mifegest Kit works in a two-step process:

  1. Mifepristone Administration: The patient takes Mifepristone orally, usually under the supervision of a healthcare provider. This step blocks progesterone, preparing the uterine lining for detachment.

  2. Misoprostol Administration: After a specific waiting period, the patient takes Misoprostol either orally or vaginally. This step induces uterine contractions, leading to the expulsion of the pregnancy.

Uses of the Mifegest Kit

first medicine taken water mifepristone and 24 hours later 3 medicine taken waters misoprostol same time

The Mifegest Kit is primarily used for medical abortion, which is a non-surgical method to terminate pregnancies within the first trimester. Some common reasons women choose medical abortion include: 

  • Unplanned pregnancies
  • Health concerns that make surgical abortion risky
  • Personal choice

It's important to note that the Mifegest Kit should only be used under the guidance of a qualified healthcare provider and in accordance with local laws and regulations.

Potential Side Effects

Like any medication, the Mifegest Kit may have side effects. Common side effects include:

  • Nausea
  • Vomiting
  • Diarrhea
  • Abdominal pain
  • Uterine bleeding

These side effects are generally mild and temporary. However, if you experience severe or persistent symptoms, it's crucial to seek immediate medical attention.

Safety and Precautions

Before using the Mifegest Kit, it's essential to inform your healthcare provider about your medical history, any allergies, or ongoing medications. This information will help ensure your safety during the medical abortion process.

Additionally, it's vital to follow the prescribed dosage and administration instructions carefully to maximize the kit's effectiveness.

The Global Landscape of Mifeget Kit: Access and Regulations

Mifegest Kit, a medication that plays a pivotal role in medication-induced abortion, has a complex and varied history of regulation and accessibility across different countries. In this comprehensive article, we delve into the global scenario surrounding mifepristone, its approval, and the diverse approaches adopted by various nations.

Australia's Evolution: From Ban to Legalization

In 1996, Australia took a decisive step by banning mifepristone. However, a significant turning point occurred in 2023 when a private member's bill surfaced in the Australian Senate. The bill aimed to lift the ban and transfer the approval authority to the Therapeutic Goods Administration (TGA). This shift triggered extensive debates within the Australian media and among politicians. In February 2006, the bill successfully passed the Senate, marking the legalization of mifepristone in Australia. Today, specialized abortion clinics in each state routinely provide mifepristone, making it accessible to those in need.

New Zealand's Right to Choose

Across the Tasman Sea in New Zealand, pro-abortion rights advocates established Istar, an import company. They submitted a request for mifepristone's approval to Medsafe, New Zealand's pharmaceutical regulatory agency. A legal challenge initiated by Right to Life New Zealand against mifepristone's use failed, resulting in its approval for use in the country.

Israel's Early Adoption

Israel stands as one of the early adopters of mifepristone, granting approval for its use in 1999. This move signified the nation's commitment to reproductive healthcare choices.

China's Unique Journey

China's relationship with mifepristone is distinctive. Clinical trials commenced in 1985, culminating in October 1988, when China became the first country worldwide to approve mifepristone. Initially facing resistance from the manufacturer, Roussel Uclaf, Chinese organizations took matters into their own hands and began domestic production in 1992. In the early 2023s, medication abortion with mifepristone faced challenges, including cost disparities compared to surgical abortion and a burgeoning black market for the drug. Women were purchasing it illegally without prescriptions, causing concerns about medical complications. Despite these challenges, mifepristone became a widely used option in Chinese cities.

Expanding Horizons in Taiwan and Vietnam

In 2001, Taiwan joined the list of countries approving mifepristone, expanding access to medication-induced abortion. Vietnam also recognized the importance of mifepristone, incorporating it into the National Reproductive Health program in 2002.

Africa's Limited Access

Mifepristone's approval in sub-Saharan Africa is limited to South Africa, where it gained approval in 2001. In North Africa, Tunisia also approved its use in the same year. These instances highlight the disparities in access to this medication across the African continent.

India's Strict Supervision

In 2002, India approved mifepristone for medication-induced abortion, terming it "medical termination of pregnancy." However, it is available only under medical supervision and not as an over-the-counter medication due to potential adverse reactions, including excessive bleeding. Criminal penalties are in place for buying or selling it on the black market or at pharmacies without proper authorization.

Canada's Shifting Landscape

In Canada, medication-induced abortion using methotrexate and misoprostol was initially available on a limited basis. Clinical trials in 2000 compared methotrexate to mifepristone, with mifepristone demonstrating faster efficacy. Health Canada granted approval for mifepristone in July 2015, initially limiting its use to seven weeks into pregnancy. However, in 2017, this limit was extended to nine weeks, and the requirement for written consent was abolished. Additionally, pharmacists and prescribing health professionals can now dispense the medication directly to patients, provided that an ultrasound confirms a non-ectopic pregnancy.

Expanding Reach in Eastern Europe and Asia

Mifepristone's approval spread to several Eastern European and Asian countries in the early 2000s. Azerbaijan, Georgia, Uzbekistan, Guyana, Moldova, Mongolia, and Armenia all registered mifepristone for use during this period, further increasing its global accessibility.

Emergency Contraception: A Different Dimension

Apart from its role in abortion, mifepristone also serves as an emergency contraception option. In China, low-dose mifepristone tablets are available directly from pharmacists without a prescription, highlighting its accessibility. In Armenia, Russia, Ukraine, and Vietnam, these tablets are available by prescription, offering an additional layer of reproductive choice.

FAQ: Mifegest kit

1. Is the Mifegest Kit Safe?

Yes, when used correctly under the guidance of a healthcare professional, the Mifegest Kit is considered safe and effective for terminating pregnancies within the recommended gestational age.

2. What Is the Ideal Gestational Age for Using the Mifegest Kit?

The Mifegest Kit is most effective when used within the first 70 days (10 weeks) of pregnancy. Beyond this point, the effectiveness may decrease.

3. How Do I Obtain the Mifegest Kit?

In many countries, the Mifegest Kit is available only by prescription and must be administered under medical supervision. It's essential to consult a healthcare provider for a proper assessment and prescription.

4. What Can I Expect During and After Taking the Mifegest Kit?

The experience can vary from person to person, but generally, after taking the medications, you can expect cramping, bleeding, and the passage of tissue. This process can last several hours or even days. It's crucial to follow the post-abortion care instructions provided by your healthcare provider.

5. Are There Any Side Effects or Risks Associated with the Mifegest Kit?

Like any medication, the Mifegest Kit can have side effects, including nausea, vomiting, diarrhea, and fever. In rare cases, serious complications may occur, so it's vital to seek immediate medical attention if you experience severe pain or heavy bleeding.

6. Can I Use the Mifegest Kit for an Ectopic Pregnancy?

No, the Mifegest Kit is not effective for treating ectopic pregnancies, which occur outside the uterus. Ectopic pregnancies require surgical intervention.

7. Is the Mifegest Kit the Right Choice for Everyone?

The decision to use the Mifegest Kit should be made after consulting with a healthcare provider. It may not be suitable for individuals with certain medical conditions or those who are not within the recommended gestational age.

8. What Support Is Available During and After Using the Mifegest Kit?

You should have access to medical support and counseling before, during, and after using the Mifegest Kit. Many healthcare providers offer guidance and emotional support to ensure you have a safe and comfortable experience.


View full details